| Name | Value |
|---|---|
| Revenues | 1,017.8M |
| Cost of Revenue | 455.3M |
| Gross Profit | 562.5M |
| Operating Expense | 319.2M |
| Operating I/L | 243.3M |
| Other Income/Expense | -31.8M |
| Interest Income | 24.0M |
| Pretax | 211.5M |
| Income Tax Expense | 41.6M |
| Net Income/Loss | 169.9M |
Hologic, Inc. is a leading provider of diagnostics products, medical imaging systems, and surgical products for women's health globally. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its offerings include molecular diagnostic assays for infectious microorganisms, viral load tests for HIV and Hepatitis, SARS-CoV-2 detection assays, breast imaging systems, minimally invasive breast biopsy guidance systems, endometrial ablation and hysteroscopic tissue removal systems, and dual energy X-ray systems for skeletal health. Hologic generates revenue through direct sales, service forces, and independent distributors, catering to the early detection and treatment needs in women's health.